Surprisingly, Western analysis of the BC markers KRT5 and TP63 contrasted the mRNA data and demonstrated an increase in the levels of protein for KRT5 and TP63 in cells treated with DAPT and DBZ relative to DMSO (Fig. 2E). This evidence concerns the gene TP63 and breast cancer.